CompletedNCT02200952

Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: San Carlo Public Hospital, Potenza, Italy
Principal Investigator: Assunta Iuliano, MD, PhD
San Carlo Public Hospital, Potenza, Italy
Intervention: recombinant LH(drug)
Enrollment: 16 target
Eligibility: 18-43 years · FEMALE
Timeline: 2013 – 2014

Study locations (1)

San carlo Public Hospital, Potenza, Basilicate, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02200952 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials